Antibody treatment given to Trump gets F.D.A. emergency approval
The treatment, made by the biotech company Regeneron, is a cocktail of two powerful antibodies that has shown promise.
— NYT: Top Stories
News Now!
Related Posts
Michelle Dryden has come full-circle back to the exciting world of news media. Dryden lives in New Jersey where she is an Independent Multimedia Journalist. With college degrees and experiences in both digital and traditional journalism since 1996, Dryden is a news veteran. The Media Pub news blog publishes core news and community features. What's your story? Email me at mdryden@themediapub.com. Cheers!!!